No profile data available.
Genenta Science S.p.A. (GNTA) is a healthcare company in the additional cancer treatment drugs industry, based in Milan, Italy, with about 9 full-time employees.
It reported revenue of 0 EUR for fiscal year 2025, and net income of -6.53 million EUR. Its market capitalization was $37.86 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. A. was incorporated in 2014 and is headquartered in Milan, Italy.
Genenta Science S.p.A. reported 0 EUR in revenue for fiscal year 2025.
$37.86 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Instil Bio, Inc. (TIL), Adlai Nortye Ltd. (ANL), NextCure, Inc. (NXTC), Cel-sci Corporation (CVM).